CoreWeave posts strong Q3 revenue growth and industry-leading MFU rates but faces high debt. Read the latest analysis on the ...

Discover how Pelthos Pharmaceuticals’ Zelsuvmi launch drives rapid revenue growth and market expansion. Click here to read my ...

IREDA shares have witnessed volaityly in the recent past, surging 632% in 13 months before tumbling 42% in just 50 sessions.

A New Market Cycle Favors the Calm, Not the Loud Why 2025 may reward structure, not speculation Investors are leaning toward projects that show clarity, roadmap confidence, and long-cycle design. IPO ...

A total of 4 000 Cell C shares changed hands at R27 each just minutes after the mobile operator’s shares debuted on the JSE.

This gold stock is eyeing a fresh entry as a key benchmark thrusts to new heights. It recently underwent an initial public ...

Why stop now? Fed Chair Jerome Powell mumbled something about "ample reserves" and pointed back to 2019, when the repo market seized up overnight and forced the Fed to rush in with emergency cash.

The third quarter earnings season is winding down, and only a handful of major companies have yet to report results. So far, ...

The third quarter earnings season is winding down, and only a handful of major companies have yet to report results. So far, ...

This is an audio transcript of the Money Clinic podcast episode: ‘The 2025 Budget: what does it mean for your money?’ Claer ...

Remember September 2019? Probably not, unless you work in finance or have anxiety issues. Corporate tax payments and a big Treasury auction hit together, cash drained and overnight repo rates jumped ...

Indonesia’s regulator has set a limit on how many shares investors can buy during initial public offerings in an effort to ...